Stefania Spada, «Directory of Approved Biopharmaceutical Products»
CRC | ISBN: 0415263689 | 2004 Year | 336 Pages | PDF | 2,14 Mb
Biopharmaceuticals, the term for genetically engineered therapeutic proteins, monoclonal antibodies, and nucleic acid-based products, have become an increasing part of the pharmaceutical armament. While this category of drugs accounts for approximately 25% of all new drugs coming to market, very few references exist that review these commercially available products. Until now, accessing data on the list of currently approved biopharmaceuticals has been laborious and patchy.